Skip to main content
. Author manuscript; available in PMC: 2010 Nov 12.
Published in final edited form as: Stroke. 2004 Mar 4;35(4):998–1004. doi: 10.1161/01.STR.0000119383.76447.05

Figure 3.

Figure 3

Presence of perlecan in microvessels of normal basal ganglia after incubation with buffer (A) and donor 2-hour ischemic tissue (B). Perlecan immunoreactivity decreased on exposure to 2-hour tissue. Bar=10 µm.

HHS Vulnerability Disclosure